Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.7, 2001-01, pp. : 537-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patent Ductus Arteriosus in the Premature Neonate: Current Concepts in Pharmacological Management

By Hammerman C. Kaplan M.

Pediatric Drugs, Vol. 1, Iss. 2, 1999-04 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

Patent Ductus Arteriosus in Premature Neonates

By Mezu-Ndubuisi Olachi J.

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 907-916

Adis International

Access to resources Recommend Favorite

Ibuprofen does not significantly reduce mesenteric or renal perfusion in preterm neonates with patent ductus arteriosus

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Ibubrofen in the Treatment of Patent Ductus Arteriosus in Preterm Infants: What We Know, What We Still Do Not Know

Current Pharmaceutical Design, Vol. 18, Iss. 21, 2012-05 ,pp. : 3007-3018

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Tolerability of Treatments for Inflammatory Bowel Disease

By Stein R.B.

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 429-448

Adis International

Access to resources Recommend Favorite